Hi Katie,
Two points: 1) The study was done "in vitro" [vs. "in vivo"], and therefore probably has little to no relation to what takes place when ascorbate is ingested, e.g. the animals all produce their own ascorbic acid daily in
multi-gram doses; and 2) Since "Dihydro-ascorbate was much less toxic or suppressive" who is to say just how the body utilizes the ascorbate, e.g. using it as ascorbate where needed, and dehydroascorbate where needed.
Frankly, my view, Katie, is that this is just the typical fear-mongering that has been going on for decades where ascorbate [and orthomolecular substances in general] is/are concerned. They are not patentable, and therefore not good for big-pharma's [and big-medicine's] bottom-line!
As just two examples: 1) If they are talking
oral consumption,
I am a good example of what "sustained megadoses of ascorbate" can do for one's health; and 2) The following example reported by Dr. Irwin Stone shows the virtually "miraculous" results possible from sustained "megadoses" of
intravenous ascorbate in the case of cancer:
"In my 1983 paper, presented at the Orthomolecular Medical Society meeting in San Francisco, I reported on the remarkable case of Joseph Kieninger, chemist and patent attorney, terminal cancer victim turned successful therapist. Joe is a prostatic cancer victim, whose cancer has spread throughout his body. He was declared terminal in 1977 and given about one year to live. By his innovative daily treatments, both systemic (beginning with 80 to 100 grams sodium ascorbate a day, every day) and topical megascorbic applications, he has survived to the present, living a painfree, relatively normal life, going to work each day and feeling good most of the time. I believe Joe is a prototype for survival in terminal disease and has shown us a new way of handling these highly scorbutic patients that Medicine has given up, and prevent them from dying of scurvy. Joe, a keen observer, wrote up and submitted his case history to the New England Journal of Medicine, but they returned his manuscript and refused publication."
Typical! Enough said?
Warm regards, Katie,
David